We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LYNKUET Bayer Australia Ltd
Product name
LYNKUET
Sponsor
Accepted date
Oct-2025
Active ingredients
elinzanetant
Proposed indication
Lynkuet (elinzanetant) is used to treat moderate to severe vasomotor symptoms (VMS; hot flushes and night sweats) that happen during menopause or that are caused by hormone therapy.
Application type
C (new indication)
Publication date
Oct-2025